Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Nächster Kursturbo?: 226 % Plus seit Januar - wie weit kann diese Aktie noch steigen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
337 Leser
Artikel bewerten:
(1)

The Business Research Company: Companies In The Parenteral Nutrition Market Are Launching Olive Oil-Based Parental Nutrition

The Business Research Company's parenteral nutrition market research report expands on key drivers, trends, and growth opportunities in the market.

LONDON, Sept. 29, 2022 /PRNewswire/ -- Olive oil-based parenteral nutrition products are gaining popularity in the parenteral nutrition market trends. The companies in the parenteral nutrition market are focusing on innovating new products such as olive oil-based parental nutrition. The olive oil provides effective nutrition, is associated with fewer infections, and confers greater ease-of-use than other oils such as soybean oil. Soybean oil-based emulsions high in linoleic acid used in parenteral nutrition (PN) could interfere with immune function and may increase the risk of septic complications. Olive oil-based emulsions, high in oleic acid, could have fewer immune effects. For example, in August 2019, Baxter International Inc., a US-based healthcare company launched Olimel N12, a new olive oil-based parental nutrition formulation to meet high protein needs in critically ill patients. The ready-to-use formulation combines a high protein formulation with low glucose content, resulting in the lowest energy to protein ratio.

The Business Research Company Logo

The global parenteral nutrition market size is expected to grow from $5.85 billion in 2021 to $6.26 billion in 2022 at a compound annual growth rate (CAGR) of 7.02%. The global parenteral nutrition market growth is expected to reach $7.99 billion in 2026 at a compound annual growth rate (CAGR) of 6.28%.

Request a free sample of the Parenteral Nutrition Market Report

An Increase In The Geriatric Population Will Drive The Growth Of The Parental Nutrition Market

As per the parenteral nutrition market analysis, an increase in the geriatric population is expected to contribute to the growth of the parental nutrition market. Geriatric population refers to the population aged 65 years and above and are considered as the old age people. The geriatric population naturally develops multiple health problems and other issues that require parental nutrition products that in turn will grow the parental nutrition market. According to the World Health Organization, a Switzerland-based government agency, by 2030, 1 in 6 people in the world will be aged 60 years or above, with the population aged 60 years and above will increase from 1 billion in 2020 to 1.4 billion in 2030.

North America Was The Largest Region In The Parenteral Nutrition Market In 2021

North America was the largest region in the parenteral nutrition market and was worth $1.96 billion in 2021. The parenteral nutrition market in North America is supported by rise in chronic diseases, and high R&D investments. The market is also supported by high healthcare expenditure in the region and increasing investments in the form of acquisitions and mergers. For example, in 2021, an estimated 14 million adults in Mexico are living with diabetes - a rise of 10% in the past.

Baxter International Inc. Held The Largest Share In The The Parenteral Nutrition Market

Baxter International, Inc was the largest competitor in the parenteral nutrition market in 2021, with a 16.55% share of the market. Baxter International Inc is a health care company that manufactures and distributes healthcare products including innovational therapies and technologies to treat patients. Baxter's growth strategy focuses on helping clinicians in meeting their patients' nutritional goals through the launch of new products. For instance, in September 2020, the company received the U.S. Food and Drug Administration (FDA) approval for the new formulations of its Clinimix E, and Clinimix injections. The Clinimix and Clinimix E with higher protein provides 60% more protein (amino acid) to the patients requiring parenteral nutrition, compared to the previous Clinimix formulations.

See more on the Parenteral Nutrition Market Report

Check out similar market reports:

Nutritional Analysis Global Market Report 2022 - By Parameter (Vitamin Profile, Mineral Profile, Total Dietary Fiber, Fat Profile, Sugar Profile, Calories, Cholesterol, Moisture), By Product Type (Beverages, Snacks, Bakery And Confectionery, Meat And Poultry, Sauces, Dressings, And Condiments, Dairy And Desserts, Fruits And Vegetables, Edible Fats And Oils, Baby Foods), By Objective (New Product Development, Product Labeling, Regulatory Compliance) - Market Size, Trends, And Global Forecast 2022-2026

Gummy Vitamins Global Market Report 2022 - By Product Type (Single Vitamin, Multi Vitamin, Probiotics), By Source (Plant, Animal), By End-User (Adult, Children), By Sales Channel (Hypermarket And Supermarket, Specialty Stores, Retail Pharmacies, Online Sales Channel) - Market Size, Trends, And Global Forecast 2022-2026

Multivitamin Capsules And Tablets Market 2022 - By Type (Multivitamins Tablets, Multivitamins Capsules), By Distribution Channel (Store Based, Non-Store Based), By Application (Energy And Weight Management, General Health, Bone And Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-Cancer), By End User (Adults, Geriatric, Pregnant Women, Children), And By Region, Opportunities And Strategies - Global Forecast To 2031

Interested to know more about The Business Research Company?

The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally, it has strategy enablement specialists in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.

The World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Logo: https://mma.prnewswire.com/media/1751581/tbrc_logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/companies-in-the-parenteral-nutrition-market-are-launching-olive-oil-based-parental-nutrition-301636914.html

© 2022 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.